SCHEMBL6858715

SCHEMBL6858715

CO[Si](C)(OC)c1ccc(N(c2ccc(N(c3cccc(C)c3)c3cccc(C)c3)cc2)c2cccc(C)c2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.35
EGFR P00533 4/20 0.35
CSF1R P07333 4/20 0.35
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
HTT P42858 2/20 0.34
TSHR P16473 1/20 0.34
MAPT P10636 2/20 0.33
POLQ O75417 2/20 0.33
HSD17B1 P14061 2/20 0.32
HSD17B2 P37059 2/20 0.32
SIGMAR1 Q99720 1/20 0.32
TDP1 Q9NUW8 2/20 0.32
NPC1 O15118 1/20 0.32
NSD2 O96028 1/20 0.32
CASP3 P42574 1/20 0.32
RAB9A P51151 1/20 0.32
SENP8 Q96LD8 1/20 0.32
SENP7 Q9BQF6 1/20 0.32
SENP6 Q9GZR1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6851656 0.95 HSD17B1 (0.37) ACHEEGFRCSF1RMEN1KMT2A
SCHEMBL6848032 0.90 ADRA2A (0.35) TSHRALDH1A1
SCHEMBL6744502 0.87 ACHE (0.35) ACHEEGFRCSF1RMEN1KMT2A
SCHEMBL6847974 0.87 ALDH1A1 (0.38) EGFRCSF1RMEN1KMT2AMAPT
SCHEMBL6851639 0.86 ADRA2A (0.33) MEN1KMT2AMAPTNPC1RAB9A
SCHEMBL6748597 0.85 ACHE (0.36) ACHEEGFRCSF1RMEN1KMT2A
SCHEMBL6851686 0.85
SCHEMBL6853136 0.84 KMT2A (0.38) ACHEMEN1KMT2AHTTTSHR
SCHEMBL6853999 0.83 ALDH1A1 (0.38) ACHEMEN1KMT2ATSHRMAPT
SCHEMBL6850575 0.83 ALDH1A1 (0.38) ACHEMEN1KMT2ATSHRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6696588-B2 OXIDATION POTENTIAL OF .3-1.5 V ON THE BASIS OF A STANDARD HYDROGEN ELECTRODE, ALKOXY AND AROMATIC AMINE DERIVATIVES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-02-24 US disclosed
EP-0861845-B1 Silicon-containing compound and organic electroluminescence device using the same SUMITOMO CHEMICAL CO (JP) 2003-05-28 EP disclosed
US-20020115877-A1 Silicon-containing compound and organic electroluminescence device using the same SUMITOMO CHEMICAL COMPANY, LIMITED 2002-08-22 US disclosed
US-6369258-B1 SILICON COMPOUND WITH OXIDATION POTENTIAL ON HYDROGEN ELECTRODE POTENTIAL SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-04-09 US disclosed
EP-0861845-A2 Silicon-containing compound and organic electroluminescence device using the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1998-09-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020115877-A1 Silicon-containing compound and organic electroluminescence device using the same EPCAM, PIEZO1, OR10J3 ACHE 363/4885EGFR 1149/4885CSF1R 3985/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.